PREVENT
Summary
To help improve the ability to detect dementia before symptoms develop and thereby increase access to early treatment.
The study purposes are to improve diagnosis of dementia and help measure effectiveness of future treatments. The specific aims are to identify the earliest features of dementia before symptoms can be detected and to understand how they progress over a period of several years. Without your help, it would be impossible to determine if the values seen in patients with transient ischemic attack are part of the normal variability between individuals or not.
Eligibility
Eligible ages: 45 to 80
Accepts healthy participants: Yes
Inclusion criteria:
Participants will be eligible to participate in either study if all of the following conditions are present:
1. Ambulatory
2. Probable TIA
3. English speaking or translator available
4. Competent to provide consent and report symptoms
5. Have no exclusion to MRI
6. Age 45-80
Exclusion criteria:
1. Non-Ambulatory
2. Not TIA or minor stroke
3. Non English speaking or translator not available
4. Not Competent to provide consent and report symptoms
5. Have exclusion to MRI
6. Participant is deaf or hard of hearing
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Supriya Save 403 944 2370 supriya.save@ahs.ca Karyn Fischer karyn.fischer@ahs.ca Dr. Philip Barber pabarber@ucalgary.ca
Principal investigator:
Philip Barber
Clinical trial:
No
REB-ID:
REB13-0240
External links